Less is more: a cost benefit analysis of a changed posology for nivolumab.

Boone, N W

Less is more: a cost benefit analysis of a changed posology for nivolumab. [electronic resource] - European journal of clinical pharmacology May 2020 - 739-740 p. digital

Publication Type: Letter

1432-1041

10.1007/s00228-020-02839-7 doi


Cost-Benefit Analysis
Humans
Neoplasms--drug therapy
Nivolumab--administration & dosage